Tetrodotoxin

河豚毒素

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameTetrodotoxin
Drug Alias Name斑蛸毒素Spheroidine章鱼毒素TetrodontoxinTarichatoxin +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type II alpha subunit blockersSodium channel protein type V alpha subunit blockersSodium channel protein type I alpha subunit blockers
TargetsSodium channel protein type II alpha subunitSodium channel protein type V alpha subunitSodium channel protein type I alpha subunit
Therapy Area/IndicationsHeroin DependencePoisoningCancer Pain +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesVirios Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Hongjintian Pharmaceutical Co LtdShanghai PPC Pharmaceutical Technology Co LtdVirios Therapeutics Inc +[4] 
Inactive CompaniesNanning Fengye Pharmaceutical Co Ltd
Active IndicationsHeroin DependenceCancer PainPain +[4] 
Inactive IndicationsPoisoning

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank